Zoll Zenix Monitor/Defibrillator Receives MDR Approval
Zoll Medical's Zenix monitor/defibrillator is now approved under the European Union's Medical Device Regulation 2017/745, commonly referred to as EU MDR.
Tag: Zoll Medical
All
Latest
Zoll Zenix Monitor/Defibrillator Receives MDR Approval
Zoll Medical’s Zenix monitor/defibrillator is now approved under the European Union’s Medical Device Regulation 2017/745, commonly referred to as EU MDR.
Read More
Zoll Medical Appoints New CEO
Zoll appointed Eric Knudsen as its new chief executive officer, effective April 1.
Read More
Zoll Completes Launch of LifeVest WCD Garment
Zoll has completed the US rollout of its next generation garment for the LifeVest wearable cardioverter defibrillator (WCD), according to the company.
Read More
Zoll-exclusive PNS Technology Included in New CSA Treatment Guidelines
New AASM treatment guidelines for central sleep apnea include the Zoll remedē System’s transvenous phrenic nerve stimulation.
Read More
Asahi Kasei Expands Critical Care Solutions with FDA-approved Zoll Zenix Monitor/Defibrillator
Zoll (an Asahi Kasei company) recently announced its Zenix monitor/defibrillator received premarket approval by the US FDA.
Read More
Zoll Zenix Monitor/Defibrillator Gets FDA Premarket Approval
Zoll Medical’s Zenix monitor/defibrillator has received premarket approval (PMA) from the US FDA, according to the company.
Read More
Real-Time CPR Coaching May Help Bystanders Take Action
Bystander confidence to administer life-saving aid like CPR rises to almost 10% if real-time coaching is available, according to a Zoll survey.
Read More
Zoll Recalls AutoPulse Nxt Resuscitation System
The FDA is reporting that Zoll has recalled its AutoPulse Nxt Resuscitation System due to a failure code that may cause the device to stop delivering chest compressions or fail to compress deeply enough, according to an FDA alert.
Read More
Zoll Closes Acquisition of Select Vyaire Ventilators
Zoll has completed its previously announced acquisition of certain assets of Vyaire Medical’s ventilator business.
Read More
Zoll AED Plus Receives EU MDR Certification
The Zoll AED Plus defibrillator is now approved under the European Union (EU) Medical Device Regulation 2017/745, commonly referred to as EU MDR, according to the company.
Read More
Zoll to Acquire Vyaire’s Ventilator Business
Zoll has secured the winning bid to acquire Vyaire Medical’s ventilator business, which is being sold as part of Vyaire’s Chapter 11 bankruptcy proceedings.
Read More
Zoll Corrects Ventilator Guides to Prevent MRI-Related Failures
ZOLL has updated the guides for its 731 Series Ventilator family to address MRI safety information and prevent potential device failures.
Read More
Vizient to Offer Zoll’s TherOx SuperSaturated Oxygen Therapy
A contract with Zoll will offer the Vizient Inc healthcare systems access to the TherOx Supersaturated Oxygen Therapy, which can benefit patients facing the most lethal of heart attacks, the LAD-STEMI.
Read More
Zoll AED 3 Receives EU MDR Certification
The Zoll AED 3 defibrillator is approved under the European Union (EU) Medical Device Regulation 2017/745, commonly referred to as EU MDR, according to the company.
Read More
Products 2023: Ventilators & Critical Care Accessories
RT looks at the latest ventilators and critical care products on the market from manufacturers Bio-Med Devices, Breas Medical, Dräger, Getinge, Movair, Turn Medical, and Zoll.
Read More
Zoll remedē System Approved for MRI Conditional Use
The US FDA approved Zoll’s remedē System, a central sleep apnea therapy, for conditional use with magnetic resonance imaging (MRI).
Read More
Supersaturated Oxygen Therapy Study to Assess Utility, Cost-effectiveness
The first patient has enrolled in a study to assess the clinical utility and cost-effectiveness of Zoll TherOx SuperSaturated Oxygen (SSO2) Therapy.
Read More
Premier Inc Signs Purchase Agreement for Zoll TherOx SSO2 Therapy
Zoll Medical Corp’s TherOx SuperSaturated Oxygen (SSO2) Therapy has been awarded a group purchasing agreement for Diagnostic and Interventional Cardiology Catheters (DIC) with Premier Inc, effective as of July 1, 2022.
Read More
Zoll to Exhibit TherOx SSO2 Therapy at Vizient Innovative Technology Exchange
Zoll will exhibit its TherOx SuperSaturated Oxygen (SSO2) Therapy at the Vizient Innovative Technology Exchange on October 17.
Read More
Supersaturated Oxygen Therapy Studied for LAD-STEMI Patients
The first patient has enrolled in a post-approval study further evaluating TherOx SuperSaturated Oxygen (SSO2) Therapy for the treatment of LAD-STEMI, the most severe form of heart attack.
Read More
CMS Issues New ICD-10 Code for Zoll TherOx SSO2 Therapy
The Centers for Medicare & Medicaid Services issued a new ICD-10-PCS code for TherOx SuperSaturated Oxygen (SSO2) Therapy, according to Zoll Medical Corp.
Read More
Zoll Launches Arrhythmia Management System
Zoll Medical Corp launched the Zoll Arrhythmia Management System, which adds biometric data including respiratory rate to the ECG information provided by traditional MCT devices.
Read More
Zoll Launches Next-Gen Mobile Cardiac Telemetry Solution
Zoll launched its Arrhythmia Management System, a mobile cardiac telemetry solution that adds biometric data to traditional MCT data to help physicians make more informed treatment plans.
Read More
Zoll Foundation Accepting Grant Applications
Zoll Foundation, which issues funding to young investigators in the fields of resuscitation and acute critical care, announced a grant application deadline is March 31, 2022.
Read More